Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS 2023-12-04 21:00
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS 2023-12-01 21:00
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
Registrational Phase III CLARIFY trial in prostate cancer commences 2023-11-30 22:16
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging 2023-11-30 22:10
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level 2023-11-30 21:59
The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023 2023-11-30 20:40
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023 2023-11-30 20:30
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results 2023-11-30 14:00
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort 2023-11-29 21:58
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device 2023-11-29 21:00
magAssist Attended 2023 ISMCS to Showcase its Next-Gen Medical Solutions that Improve Treatment Outcomes of Critical Heart Diseases 2023-11-29 14:06
Wonder Tech's Breakthrough in Language Agnostic Voice AI to Bring Scalable Depression Screening to One Billion People Globally 2023-11-29 00:00
Rhino Rescue Expands Horizons at Medica 2023, Exploring New Opportunities in the European Market 2023-11-28 23:00
Dr. Liu Jian, President of Medicilon Drug Discovery Division, wins the Thomas Alva Edison Patent Award 2023-11-28 21:30
Akeso Launches Construction of Shanghai Global R&D Center to Accelerate Its Innovation Globalization Strategy 2023-11-28 21:00
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology 2023-11-27 22:05
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients 2023-11-27 21:30
Ascentage Pharma Hosts Ceremony Marking the Launch of Olverembatinib in Newly Approved Indication and the Dispatch of First Batch for the New Indication 2023-11-24 19:57
1 49 50 51 52 53 431